Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: The BRIDGE-ACS randomized trial

JAMA

Volumn 307, Issue 19, 2012, Pages 2041-2049

  Berwanger, Otávio ^a   Guimarães, Hélio P ^a   Laranjeira, Ligia N ^a,b   Cavalcanti, Alexandre B ^a   Kodama, Alessandra A ^a   Zazula, Ana Denise ^a   Santucci, Eliana V ^a   Victor, Elivane ^a   Tenuta, Marcos ^a   Carvalho, Vitor ^a   Mira, Vera Lucia ^a   Pieper, Karen S ^c   Weber, Bernardete ^a   Mota, Luiz Henrique ^a   Peterson, Eric D ^c   Lopes, Renato D ^b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FONDAPARINUX; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; ALGORITHM; ARTICLE; BRAZIL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TEACHING HOSPITAL; URBAN AREA;

EID: 84861058142     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.413     Document Type: Article

References (47)

1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases, I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104 (22):2746-2753. (Pubitemid 33108145)
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases, II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104(23):2855- 2864. (Pubitemid 33126663)
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 1994;343(8893):311-322.
4. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13-20. (Pubitemid 36050955)
5. Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999; 318(7200):1730-1737. (Pubitemid 29290470)
6. Chen ZM, Jiang LX, Chen YP, et al COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366(9497):1607-1621.
7. Wenger NK. 2011 ACCF/AHA focused update of the guidelines for the management of patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 Guideline): highlights for the clinician. Clin Cardiol. 2012;35(1):3-8.
8. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in J Am Coll Cardiol. 2010;55(6):612]. J Am Coll Cardiol. 2009;54(23): 2205-2241.
9. Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes: variations in practice and outcome: findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2002; 23(15):1177-1189. (Pubitemid 35215244)
10. Hoekstra JW, Pollack CV Jr, Roe MT, et al. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med. 2002; 9(11):1146-1155. (Pubitemid 35291543)
11. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? a framework for improvement. JAMA. 1999;282(15):1458-1465. (Pubitemid 29493800)
12. Budaj A, Brieger D, Steg PG, et al GRACE Investigators. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2003;146(6):999-1006. (Pubitemid 37500773)
13. Yusuf S, Islam S, Chow CK, et al Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middleincome, and low-income countries (the PURE study): a prospective epidemiological survey. Lancet. 2011; 378(9798):1231-1243.
14. Mattos LA. Rationality and methods of ACCEPT registry - Brazilian registry of clinical practice in acute coronary syndromes of the Brazilian Society of Cardiology. Arq Bras Cardiol. 2011;97(2):94-99.
15. How we classify countries. World Bank website. http://data.worldbank.org/ about/country -classifications. Accessed February 25, 2012.
16. Bonetti D, Eccles M, Johnston M, et al. Guiding the design and selection of interventions to influence the implementation of evidence-based practice: an experimental simulation of a complex intervention trial. Soc Sci Med. 2005;60(9):2135-2147. (Pubitemid 40311730)
17. Grimshaw J, Eccles M, Thomas R, et al. Toward evidence-based quality improvement: evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998. J Gen Intern Med. 2006;21(suppl 2):S14-S20.
18. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;39(8)(suppl 2):II2-II45. (Pubitemid 33752649)
19. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet. 2005;366(9496):1578-1582. (Pubitemid 41540116)
20. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063): 1436-1442. (Pubitemid 27212192)
21. Berwanger O, Guimarães HP, Laranjeira LN, et al. A multifaceted intervention to narrow the evidence-based gap in the treatment of acute coronary syndromes: rationale and design of the BRIDGE-ACS cluster- randomized trial. Am Heart J. 2012;163(3): 323-329.
22. Buyse M, George SL, Evans S, et al. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med. 1999; 18(24):3435-3451. (Pubitemid 30041358)
23. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295(16):1912-1920.
24. Patti G, Cannon CP, Murphy SA, et al. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient- level meta-analysis of 13 randomized studies. Circulation. 2011;123(15):1622-1632.
25. Cannon CP, Braunwald E, McCabe CH, et al; Pravastatin or Atorvastatin Evaluation and Infection Therapy - Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350(15):1495-1504.
26. Hayes RL, Moulton LH. Cluster Randomised Trials. Boca Raton, FL: Chapman & Hall/CRC; 2009.
27. Kerry SM, Bland JM. Sample size in cluster randomisation. BMJ. 1998;316(7130):549.
28. Campbell MJ, Donner A, Klar N. Developments in cluster randomized trials and Statistics in Medicine. Stat Med. 2007;26(1):2-19. (Pubitemid 46099414)
29. Patel MR, Chen AY, Roe MT, et al. A comparison of acute coronary syndrome care at academic and nonacademic hospitals. Am J Med. 2007;120(1): 40-46. (Pubitemid 46026990)
30. Halabi AR, Eisenberg MJ, Richard H, et al. Impact of on-site cardiac catheterization on cardiac procedure use and quality of life after acute myocardial infarction. Can J Cardiol. 2001;17(suppl C):152C.
31. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl JMed. 1994;331(17):1136-1142. (Pubitemid 24321220)
32. Allison JJ, Kiefe CI, Weissman NW, et al. Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI. JAMA. 2000;284(10):1256-1262.
33. Kreuter F, Valliant R. A survey on survey statistics: what is done and can be done in Stata. Stata J. 2011;7(suppl 1):1-21.
34. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
35. Schmidt MI, Duncan BB, Azevedo e Silva G, et al. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet. 2011;377(9781): 1949-1961.
36. Mehta RH, Montoye CK, Gallogly M, et al GAP Steering Committee of the American College of Cardiology. Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002;287(10):1269-1276. (Pubitemid 34250481)
37. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001;87(7):819-822. (Pubitemid 32244197)
38. Carlhed R, Bojestig M, Wallentin L, et al QUICC Study Group. Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study. Am Heart J. 2006;152(6):1175-1181. (Pubitemid 44854807)
39. Grimshaw J, Campbell M, Eccles M, Steen N. Experimental and quasi-experimental designs for evaluating guideline implementation strategies. Fam Pract. 2000;17(suppl 1):S11-S16. (Pubitemid 30105646)
40. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ. 2003;327(7418):785-789.
41. Beck CA, Richard H, Tu JV, Pilote L. Administrative Data Feedback for Effective Cardiac Treatment: AFFECT, a cluster randomized trial. JAMA. 2005; 294(3):309-317. (Pubitemid 41043774)
42. Grimshaw J, Eccles M, Campbell M, Elbourne D. Cluster randomized trials of professional and organizational behavior change interventions in health care settings. Ann Am Acad Pol Soc Sci. 2005;599(1): 71-93. (Pubitemid 40580091)
43. Flather M, Booth J. Prospective registry of outcomes and management in ischaemic syndromes. Presented at: World Congress of Cardiology; September 2-6, 2006; Barcelona, Spain.
44. Flather MD, Booth J, Babalis D, et al. Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design. Trials. 2010; 11:5.
45. Flather MD, Babalis D, Booth J, et al. Clusterrandomized trial to evaluate the effects of a quality improvement program on management of non-STelevation acute coronary syndromes: the European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS). Am Heart J. 2011; 162(4):700-707, e1.
46. Eapen ZJ, Fonarow GC, Dai D, et al Get With The Guidelines Steering Committee and Hospitals. Comparison of composite measure methodologies for rewarding quality of care: an analysis from the American Heart Association's Get With The Guidelines program. Circ Cardiovasc Qual Outcomes. 2011; 4(6):610-618.
47. Polanczyk CA, Biolo A, Imhof BV, et al. Improvement in clinical outcomes in acute coronary syndromes after the implementation of a critical pathway. Crit Pathw Cardiol. 2003;2(4):222-230. (Pubitemid 37509548)